Clinical problem-solving. High time for action. Kallianpur AR, Poehling KA, Dittus RS (2001) N Engl J Med 344: 48-51 Factor XI antisense oligonucleotide for prevention of venous thrombosis. Büller HR, Bethune C, Bhanot S, Gailani D, Monia BP, Raskob GE, Segers A, Verhamme P, Weitz JI, FXI-ASO TKA Investigators (2015) N Engl J Med 372: 232-40 Endotoxin-sensitive membrane component of human platelets. Hawiger J, Hawiger A, Timmons S (1975) Nature 256: 125-7 Ratcheting of the substrate from the zymogen to proteinase conformations directs the sequential cleavage of prothrombin by prothrombinase. Bianchini EP, Orcutt SJ, Panizzi P, Bock PE, Krishnaswamy S (2005) Proc Natl Acad Sci U S A 102: 10099-104 Factor IX is activated in vivo by the tissue factor mechanism. Bauer KA, Kass BL, ten Cate H, Hawiger JJ, Rosenberg RD (1990) Blood 76: 731-6 A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Cheng Q, Tucker EI, Pine MS, Sisler I, Matafonov A, Sun MF, White-Adams TC, Smith SA, Hanson SR, McCarty OJ, Renné T, Gruber A, Gailani D (2010) Blood 116: 3981-9 Factor XI contributes to thrombin generation in the absence of factor XII. Kravtsov DV, Matafonov A, Tucker EI, Sun MF, Walsh PN, Gruber A, Gailani D (2009) Blood 114: 452-8 Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation. Gailani D, Broze GJ (1993) Blood 82: 813-9 Factor XII inhibition reduces thrombus formation in a primate thrombosis model. Matafonov A, Leung PY, Gailani AE, Grach SL, Puy C, Cheng Q, Sun MF, McCarty OJ, Tucker EI, Kataoka H, Renné T, Morrissey JH, Gruber A, Gailani D (2014) Blood 123: 1739-46 A hereditary bleeding disorder of dogs caused by a lack of platelet procoagulant activity. Brooks MB, Catalfamo JL, Brown HA, Ivanova P, Lovaglio J (2002) Blood 99: 2434-41 Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress. Bastarache JA, Sebag SC, Clune JK, Grove BS, Lawson WE, Janz DR, Roberts LJ, Dworski R, Mackman N, Ware LB (2012) Thorax 67: 1032-9 The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor. Bastarache JA, Wang L, Geiser T, Wang Z, Albertine KH, Matthay MA, Ware LB (2007) Thorax 62: 608-16 Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor. Despotis GJ, Hogue CW, Santoro SA, Joist JH, Barnes PW, Lappas DG (1995) Crit Care Med 23: 1674-9 Excess of heme induces tissue factor-dependent activation of coagulation in mice. Sparkenbaugh EM, Chantrathammachart P, Wang S, Jonas W, Kirchhofer D, Gailani D, Gruber A, Kasthuri R, Key NS, Mackman N, Pawlinski R (2015) Haematologica 100: 308-14 Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocolitica. Luo D, Szaba FM, Kummer LW, Plow EF, Mackman N, Gailani D, Smiley ST (2011) J Immunol 187: 1866-76 Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation. Massion PB, Peters P, Ledoux D, Zimermann V, Canivet JL, Massion PP, Damas P, Gothot A (2012) Intensive Care Med 38: 1326-35 On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery. Despotis GJ, Santoro SA, Spitznagel E, Kater KM, Barnes P, Cox JL, Lappas DG (1994) Anesthesiology 80: 338-51 Tissue factor and platelet glycoprotein Ib-alpha alleles are associated with age at first coronary bypass operation. Donahue BS, Byrne DW, Gailani D, George AL (2003) Anesthesiology 99: 1287-94 Monitoring activity of fibrinolytic agents. A therapeutic challenge. Shafer KE, Santoro SA, Sobel BE, Jaffe AS (1984) Am J Med 76: 879-86 Mechanical stretch inhibits lipopolysaccharide-induced keratinocyte-derived chemokine and tissue factor expression while increasing procoagulant activity in murine lung epithelial cells. Sebag SC, Bastarache JA, Ware LB (2013) J Biol Chem 288: 7875-7884 Active site-labeled prothrombin inhibits prothrombinase in vitro and thrombosis in vivo. Kroh HK, Panizzi P, Tchaikovski S, Baird TR, Wei N, Krishnaswamy S, Tans G, Rosing J, Furie B, Furie BC, Bock PE (2011) J Biol Chem 286: 23345-56 Restricted active site docking by enzyme-bound substrate enforces the ordered cleavage of prothrombin by prothrombinase. Hacisalihoglu A, Panizzi P, Bock PE, Camire RM, Krishnaswamy S (2007) J Biol Chem 282: 32974-82 Tissue factor expression during human and mouse development. Luther T, Flössel C, Mackman N, Bierhaus A, Kasper M, Albrecht S, Sage EH, Iruela-Arispe L, Grossmann H, Ströhlein A, Zhang Y, Nawroth PP, Carmeliet P, Loskutoff DJ, Müller M (1996) Am J Pathol 149: 101-13 The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis. Krikun G, Hu Z, Osteen K, Bruner-Tran KL, Schatz F, Taylor HS, Toti P, Arcuri F, Konigsberg W, Garen A, Booth CJ, Lockwood CJ (2010) Am J Pathol 176: 1050-6 Regulation of alveolar procoagulant activity and permeability in direct acute lung injury by lung epithelial tissue factor. Shaver CM, Grove BS, Putz ND, Clune JK, Lawson WE, Carnahan RH, Mackman N, Ware LB, Bastarache JA (2015) Am J Respir Cell Mol Biol 53: 719-27 Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear. Berny MA, Munnix IC, Auger JM, Schols SE, Cosemans JM, Panizzi P, Bock PE, Watson SP, McCarty OJ, Heemskerk JW (2010) PLoS One 5: e10415 Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome. Bastarache JA, Fremont RD, Kropski JA, Bossert FR, Ware LB (2009) Am J Physiol Lung Cell Mol Physiol 297: L1035-41 Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity. Bastarache JA, Wang L, Wang Z, Albertine KH, Matthay MA, Ware LB (2008) Am J Physiol Lung Cell Mol Physiol 294: L874-81 Activation of intrinsic blood coagulation by ellagic acid: insoluble ellagic acid-metal ion complexes are the activating species. Bock PE, Srinivasan KR, Shore JD (1981) Biochemistry 20: 7258-66 The coagulation cascade in sepsis. Wang L, Bastarache JA, Ware LB (2008) Curr Pharm Des 14: 1860-9 In vitro reversal of heparin effect with heparinase: evaluation with whole blood prothrombin time and activated partial thromboplastin time in cardiac surgical patients. Despotis GJ, Summerfield AL, Joist JH, Goodnough LT, Santoro SA, Zimmermann JJ, Lappas DG (1994) Anesth Analg 79: 670-4 Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations. Chaturvedi S, Cockrell E, Espinola R, Hsi L, Fulton S, Khan M, Li L, Fonseca F, Kundu S, McCrae KR (2015) Thromb Res 135: 102-8 Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome. Sebag SC, Bastarache JA, Ware LB (2011) Curr Pharm Biotechnol 12: 1481-96 Markers of inflammation and coagulation may be modulated by enteral feeding strategy. Bastarache JA, Ware LB, Girard TD, Wheeler AP, Rice TW (2012) JPEN J Parenter Enteral Nutr 36: 732-40 Interferon-γ and tumor necrosis factor-α act synergistically to up-regulate tissue factor in alveolar epithelial cells. Bastarache JA, Sebag SC, Grove BS, Ware LB (2011) Exp Lung Res 37: 509-17 A murine model of factor XI deficiency. Gailani D, Lasky NM, Broze GJ (1997) Blood Coagul Fibrinolysis 8: 134-44
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.